نتایج جستجو برای: oral glucose tolerance tests

تعداد نتایج: 840476  

Journal: :Gut 1960
P BURTON E M HAMMOND A A HARPER H T HOWAT J E SCOTT H VARLEY

A simple evocative test has been used to study pancreatic function. Serial estimations of amylase and lipase in blood serum are made at intervals up to six hours and again at 24 hours after injecting intravenously standard doses of secretin and pancreozymin. The results of 213 tests on a normal group, in pancreatic disease, in biliary and hepatic diseases have been analysed and compared with th...

Journal: :The Journal of nutrition 2006
Kristof Vanschoonbeek Bregje J W Thomassen Joan M Senden Will K W H Wodzig Luc J C van Loon

In vitro and in vivo animal studies have reported strong insulin-like or insulin-potentiating effects after cinnamon administration. Recently, a human intervention study showed that cinnamon supplementation (1 g/d) strongly reduced fasting blood glucose concentration (30%) and improved the blood lipid profile in patients with type 2 diabetes. The objective of this study was to investigate the e...

2013
Kristine Færch Giovanni Pacini John J. Nolan Torben Hansen Andrea Tura Dorte Vistisen

OBJECTIVE We studied whether patterns of glucose absorption during oral glucose tolerance tests (OGTTs) were abnormal in individuals with impaired glucose regulation and whether they were related to sex and body size (height and fat-free mass). We also examined how well differences in insulin sensitivity and β-cell function measured by gold-standard tests were reflected in the corresponding OGT...

Journal: :The Journal of clinical investigation 1968
G Boden J S Soeldner R E Gleason A Marble

Serum human growth hormone (HGH), serum immunoreactive insulin (IRI), plasma free fatty acids, and blood glucose were measured during intravenous glucose and intravenous tolbutamide tolerance tests in 13 normal and 13 prediabetic (offspring of two diabetic parents) males, closely matched for weight and age. Only prediabetics with normal glucose tolerance during oral, intravenous, and cortisone-...

2006
Melanie Davies Huw Alban-Davies Christopher Cook

Objective-To develop a simple, economically viable, and effective means of population screening for diabetes mellitus. Design-A postal request system for self testing for glycosuria with foil wrapped dipsticks. Preprandial and postprandial tests were compared with a single postprandial test. The subjects were instructed how to test, and a result card was supplied on which to record and return t...

2013
ANA CAROLINA JUNQUEIRA FERNANDA SATAKE MARCELO MIRANDA FRANCESCA PICCININI

RESEARCH DESIGN AND METHODSdSixty-eight women were divided into the following three groups: 19 lean-control (23.06 2.2 kg/m) and 18 obese-control (35.06 4.8 kg/m) subjects with normal glucose tolerance, and 31 obese patients with type 2 diabetes (36.36 3.7 kg/m). Of the 31 diabetic women, 64% underwent BPD (n = 20, BMI: 36.56 3.7 kg/m) and were reassessed 1 month after surgery. Oral glucose tol...

2013
Ana Carolina Junqueira Vasques José Carlos Pareja Maria da Saude de Oliveira Fernanda Satake Novaes Marcelo Miranda de Oliveira Lima Élinton A. Chaim Francesca Piccinini Chiara Dalla Man Claudio Cobelli Bruno Geloneze

OBJECTIVE To investigate the effect of biliopancreatic diversion (BPD) surgery on β-cell function in grade I and II obese patients with type 2 diabetes using oral and intravenous glucose loads. RESEARCH DESIGN AND METHODS Sixty-eight women were divided into the following three groups: 19 lean-control (23.0 ± 2.2 kg/m(2)) and 18 obese-control (35.0 ± 4.8 kg/m(2)) subjects with normal glucose t...

Journal: :Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 1990

Journal: :The Journal of pharmacology and experimental therapeutics 2012
Masayuki Suzuki Kiyofumi Honda Masanori Fukazawa Kazuharu Ozawa Hitoshi Hagita Takahiro Kawai Minako Takeda Tatsuo Yata Mio Kawai Taku Fukuzawa Takamitsu Kobayashi Tsutomu Sato Yoshiki Kawabe Sachiya Ikeda

Sodium/glucose cotransporter 2 (SGLT2) is the predominant mediator of renal glucose reabsorption and is an emerging molecular target for the treatment of diabetes. We identified a novel potent and selective SGLT2 inhibitor, tofogliflozin (CSG452), and examined its efficacy and pharmacological properties as an antidiabetic drug. Tofogliflozin competitively inhibited SGLT2 in cells overexpressing...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید